Gene · 8000
Papers1,687
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 1,687
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Expression of Mucin Family Proteins in Non-Small-Cell Lung Cancer and its Role in Evaluation of Prognosis. | J Oncol | 2022 | 36059804 | PubTator, text mining | PubMed |
| High dose androgen suppresses natural killer cytotoxicity of castration-resistant prostate cancer cells via altering AR/circFKBP5/miRNA-513a-5p/PD-L1 signals. | Cell Death Dis | 2022 | 36038573 | PubTator, text mining | PubMed |
| The Cellular and Molecular Immunotherapy in Prostate Cancer. | Vaccines (Basel) | 2022 | 36016257 | PubTator, text mining | PubMed |
| STEAP1-4 (Six-Transmembrane Epithelial Antigen of the Prostate 1-4) and Their Clinical Implications for Prostate Cancer. | Cancers (Basel) | 2022 | 36011027 | PubTator, text mining | PubMed |
| SNP rs2920280 in PSCA Is Associated with Susceptibility to Gastric Mucosal Atrophy and Is a Promising Biomarker in Japanese Individuals with Helicobacter pylori Infection. | Diagnostics (Basel) | 2022 | 36010338 | PubTator, text mining | PubMed |
| Developing New Treatment Options for Castration-Resistant Prostate Cancer and Recurrent Disease. | Biomedicines | 2022 | 36009418 | PubTator, text mining | PubMed |
| Immunotherapy in non-small cell lung cancer: Past, present, and future directions. | Front Oncol | 2022 | 35992832 | PubTator, text mining | PubMed |
| DDX5 and DDX17-multifaceted proteins in the regulation of tumorigenesis and tumor progression. | Front Oncol | 2022 | 35992805 | PubTator, text mining | PubMed |
| Advances and challenges of CAR T therapy and suitability of animal models (Review). | Mol Clin Oncol | 2022 | 35949897 | PubTator, text mining | PubMed |
| CAR T-Cell-Based gene therapy for cancers: new perspectives, challenges, and clinical developments. | Front Immunol | 2022 | 35936003 | PubTator, text mining | PubMed |
| The efficacy and safety of chimeric antigen receptor T cells in digestive system cancers: a systematic review and meta-analysis. | Ann Transl Med | 2022 | 35928759 | PubTator, text mining | PubMed |
| Clinical Investigations of CAR-T Cell Therapy for Solid Tumors. | Front Immunol | 2022 | 35924243 | PubTator, text mining | PubMed |
| Emerging approaches for preventing cytokine release syndrome in CAR-T cell therapy. | J Mater Chem B | 2022 | 35912720 | PubTator, text mining | PubMed |
| Chimeric Antigen Receptor (CAR)-T Cell Immunotherapy Against Thoracic Malignancies: Challenges and Opportunities. | Front Immunol | 2022 | 35911706 | PubTator, text mining | PubMed |
| Revolution of CAR Engineering For Next-Generation Immunotherapy In Solid Tumors. | Front Immunol | 2022 | 35903099 | PubTator, text mining | PubMed |
| Biochemical Intracystic Biomarkers in the Differential Diagnosis of Pancreatic Cystic Lesions. | Medicina (Kaunas) | 2022 | 35893110 | PubTator, text mining | PubMed |
| Combining Radiation- with Immunotherapy in Prostate Cancer: Influence of Radiation on T Cells. | Int J Mol Sci | 2022 | 35887271 | PubTator, text mining | PubMed |
| Nonviral mcDNA-mediated bispecific CAR T cells kill tumor cells in an experimental mouse model of hepatocellular carcinoma. | BMC Cancer | 2022 | 35879685 | PubTator, text mining | PubMed |
| Chemotherapy and Physical Therapeutics Modulate Antigens on Cancer Cells. | Front Immunol | 2022 | 35874714 | PubTator, text mining | PubMed |
| From Anti-HER-2 to Anti-HER-2-CAR-T Cells: An Evolutionary Immunotherapy Approach for Gastric Cancer. | J Inflamm Res | 2022 | 35873388 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8000/papers?page=17